Page last updated: 2024-10-16

gamma-aminobutyric acid and Alpers Diffuse Degeneration of Cerebral Gray Matter with Hepatic Cirrhosis

gamma-aminobutyric acid has been researched along with Alpers Diffuse Degeneration of Cerebral Gray Matter with Hepatic Cirrhosis in 2 studies

gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.

Research Excerpts

ExcerptRelevanceReference
"A patient with hepatic cirrhosis due to Alpers disease is described who had a significantly raised plasma alanine aminotransferase (ALT) activity of 247 U/L which returned to normal (18 U/L) shortly after commencing treatment with the anticonvulsant drug, vigabatrin."1.30Suppression of elevated alanine aminotransferase activity in liver disease by vigabatrin. ( Coakley, J; Sekaninova, S; Williams, A, 1998)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jaeken, J1
Casaer, P1
de Cock, P1
Corbeel, L1
Eeckels, R1
Eggermont, E1
Schechter, PJ1
Brucher, JM1
Williams, A1
Sekaninova, S1
Coakley, J1

Other Studies

2 other studies available for gamma-aminobutyric acid and Alpers Diffuse Degeneration of Cerebral Gray Matter with Hepatic Cirrhosis

ArticleYear
Gamma-aminobutyric acid-transaminase deficiency: a newly recognized inborn error of neurotransmitter metabolism.
    Neuropediatrics, 1984, Volume: 15, Issue:3

    Topics: 4-Aminobutyrate Transaminase; beta-Alanine; Brain; Carnosine; Diffuse Cerebral Sclerosis of Schilder

1984
Suppression of elevated alanine aminotransferase activity in liver disease by vigabatrin.
    Journal of paediatrics and child health, 1998, Volume: 34, Issue:4

    Topics: Alanine Transaminase; Anticonvulsants; Diffuse Cerebral Sclerosis of Schilder; Enzyme Inhibitors; Fa

1998